|
| |
| | | 70733 | | 04.05.2026 | | Sandoz Pharmaceuticals AG | | | | | | | 03.05.2031 | | | | | | | | | | 07.16.10. | | |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Ruxolitinib Sandoz 5 mg | Tabletten | Tabletten (Ruxolitinibum 5 mg) | L01EJ01 | | | 02 | Ruxolitinib Sandoz 10 mg | Tabletten | Tabletten (Ruxolitinibum 10 mg) | L01EJ01 | | | 03 | Ruxolitinib Sandoz 15 mg | Tabletten | Tabletten (Ruxolitinibum 15 mg) | L01EJ01 | | | 04 | Ruxolitinib Sandoz 20 mg | Tabletten | Tabletten (Ruxolitinibum 20 mg) | L01EJ01 | |
|
|
|
